Akihiro Tomida Selected Research

fluorexon (calcein)

1/2008	Bioactive triterpene saponins from the roots of Phytolacca americana.
7/2007	Bioactive cardenolides from the stems and twigs of Nerium oleander.
4/2007	Bioactive lignans from Peperomia duclouxii.
2/2007	Structure-activity relationships of some taxoids as multidrug resistance modulator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Tomida Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 08/2002
6	Starvation 01/2022 - 09/2002
4	Melanoma (Melanoma, Malignant) 10/2021 - 12/2011
4	Hypoxia (Hypoxemia) 02/2017 - 09/2002
4	Ovarian Neoplasms (Ovarian Cancer) 01/2008 - 02/2004
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 09/2004
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 11/2007
2	Stomach Neoplasms (Stomach Cancer) 12/2011 - 09/2004
1	Disease Progression 04/2019
1	Rectal Neoplasms (Rectal Cancer) 04/2019
1	Carcinoid Tumor (Carcinoid) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2011
1	AIDS-Related Complex (ARC) 07/2010
1	Dermatitis 10/2008
1	Radiodermatitis 10/2008
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Carcinoma (Carcinomatosis) 04/2008
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2007
1	Hypoglycemia (Reactive Hypoglycemia) 09/2004
1	Fibrosarcoma 09/2004
1	Hematologic Neoplasms (Hematological Malignancy) 01/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2002

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2002
6	Antineoplastic Agents (Antineoplastics)IBA 03/2013 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
4	Phosphotransferases (Kinase)IBA 01/2020 - 07/2004
4	fluorexon (calcein)IBA 01/2008 - 02/2007
3	EnzymesIBA 07/2014 - 07/2004
3	Pharmaceutical PreparationsIBA 01/2014 - 11/2002
2	Activating Transcription Factor 4IBA 01/2022 - 01/2017
2	VemurafenibIBA 10/2021 - 01/2017
2	Amino Acids FDA Link 12/2020 - 01/2017
2	Peptide Initiation Factors (Initiation Factor)IBA 10/2018 - 01/2017
2	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 07/2014 - 05/2013
2	BiguanidesIBA 05/2012 - 01/2011
2	Endoplasmic Reticulum Chaperone BiPIBA 07/2010 - 04/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2008 - 11/2002
2	Etoposide (VP 16)FDA LinkGeneric 04/2008 - 02/2004
2	trioctyl phosphine oxide (TOPO)IBA 11/2007 - 07/2004
2	Verapamil (Calan)FDA LinkGeneric 04/2007 - 04/2005
2	taxinineIBA 02/2007 - 01/2004
2	Cisplatin (Platino)FDA LinkGeneric 09/2004 - 02/2004
2	Antisense OligonucleotidesIBA 07/2004 - 02/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2004 - 09/2002
2	CamptothecinIBA 02/2004 - 11/2002
2	Imatinib Mesylate (Gleevec)FDA Link 01/2003 - 08/2002
1	spautin-1IBA 01/2022
1	Ubiquitin-Specific ProteasesIBA 01/2022
1	AsparagineIBA 10/2021
1	eIF-4BIBA 10/2021
1	lamellarin 14IBA 05/2021
1	Transcription Factor 4IBA 12/2020
1	olverembatinibIBA 12/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Leucine-Rich Repeat ProteinsIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 04/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Small Interfering RNA (siRNA)IBA 01/2017
1	AndrogensIBA 10/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2016
1	Triglycerides (Triacylglycerol)IBA 07/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2014
1	CarbonIBA 01/2014
1	chrysoplenetinIBA 12/2011
1	Cytotoxins (Cytolysins)IBA 12/2011
1	versipelostatinIBA 01/2011
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 07/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2010
1	arctigeninIBA 07/2010
1	Caspase 9IBA 07/2010
1	Mitochondrial DNA (mtDNA)IBA 05/2010
1	piericidin AIBA 04/2008
1	beta CateninIBA 11/2007
1	taxuyunnanine CIBA 07/2007
1	oxetaneIBA 02/2007
1	taxusinIBA 04/2005
1	Calcium IonophoresIBA 09/2004
1	Deoxyglucose (2 Deoxy D glucose)IBA 09/2004
1	Calcimycin (A23187)IBA 09/2004
1	TunicamycinIBA 09/2004
1	Green Fluorescent ProteinsIBA 07/2004
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2004
1	CurcuminIBA 07/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2004
1	AntibodiesIBA 01/2003
1	Lactoylglutathione LyaseIBA 01/2003
1	Trastuzumab (Herceptin)FDA Link 01/2003
1	Gefitinib (Iressa)FDA Link 01/2003
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2002
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 09/2002
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 09/2002
1	Tyrosine Kinase InhibitorsIBA 08/2002
1	Complementary DNA (cDNA)IBA 08/2002

Therapy/Procedure

7	Therapeutics 12/2020 - 01/2003
3	Drug Therapy (Chemotherapy) 04/2019 - 08/2002
1	Neoadjuvant Therapy 04/2019
1	Pancreaticoduodenectomy 01/2013
1	Radiotherapy 10/2008
1	Segmental Mastectomy (Lumpectomy) 10/2008